Among older men and women, those with type 2 diabetes have lower baseline general cognition scores and experience a steeper cognitive decline subsequently, according to findings published in the June issue of the Journal of the American Geriatric Society. Reuters Health Information
Men with increased body mass index (BMI) generally have relatively low prostate specific antigen (PSA) levels even when prostate findings are abnormal -- and thus cancers may be missed or not detected promptly -- according to US and Canadian researchers. Reuters Health Information
Four factors (total number of embryos, number of 8-cell embryos, percentage of embryos that stopped dividing, and maternal FSH), when combined, were 70% accurate in predicting pregnancy after IVF. Medscape Medical News
A study shows that meeting target ranges recommended by the National Kidney Foundation for all 3 markers was associated with improved survival vs controlling fewer markers. Medscape Medical News
The data may seem confusing, but in this video blog Dr. Anne Peters explains how these trials can help us better manage our diabetes patients. Medscape Diabetes & Endocrinology
Regional differences in diabetes prevalence may contribute to the geographic disparity in stroke mortality seen in the United States, independent of hypertension. Reuters Health Information
As a treatment for morbid obesity, Roux-en-Y gastric bypass (RYGB) appears to increase the risk of calcium oxalate kidney stones, according to a report in the Journal of the American College of Surgeons for June. Reuters Health Information
The results of the Arterial Revascularization Therapies Study Part II (ARTS II) show that body mass index (BMI) "had no impact on one-year clinical outcomes in patients with multi-vessel coronary artery disease treated with sirolimus-eluting stents," principal investigator Dr. Ahmed A. Khattab of the Segeberger Kliniken in Bad Segeberg, Germany, and colleagues report. Reuters Health Information
The experimental drug motesanib might be "clinically useful" in progressive differentiated thyroid disease, say researchers reporting a phase 2 trial. Medscape Medical News